Literature DB >> 10660790

Does raloxifene reduce postmenopausal women's risk of breast cancer?

R K Han1, N Pimlott, R Heisey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660790      PMCID: PMC1987633     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

1.  Risk factors, lifetime risk, and age at onset of breast cancer.

Authors:  G E Fraser; D Shavlik
Journal:  Ann Epidemiol       Date:  1997-08       Impact factor: 3.797

2.  Rapid and simple prenatal DNA diagnosis of Down's syndrome.

Authors:  L Verma; F Macdonald; P Leedham; M McConachie; S Dhanjal; M Hultén
Journal:  Lancet       Date:  1998-07-04       Impact factor: 79.321

Review 3.  Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature.

Authors:  M M Seidl; D E Stewart
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

4.  Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

Authors:  P D Delmas; N H Bjarnason; B H Mitlak; A C Ravoux; A S Shah; W J Huster; M Draper; C Christiansen
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

Review 5.  Selective estrogen receptor modulators: Women's panacea for the next millennium?

Authors:  C P Spencer; E P Morris; J M Rymer
Journal:  Am J Obstet Gynecol       Date:  1999-03       Impact factor: 8.661

6.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Authors:  S R Cummings; S Eckert; K A Krueger; D Grady; T J Powles; J A Cauley; L Norton; T Nickelsen; N H Bjarnason; M Morrow; M E Lippman; D Black; J E Glusman; A Costa; V C Jordan
Journal:  JAMA       Date:  1999-06-16       Impact factor: 56.272

7.  Risks and probabilities of breast cancer: short-term versus lifetime probabilities.

Authors:  H E Bryant; P M Brasher
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

8.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

9.  Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.

Authors:  U Veronesi; P Maisonneuve; A Costa; V Sacchini; C Maltoni; C Robertson; N Rotmensz; P Boyle
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

10.  Compliance with hormone therapy.

Authors:  V A Ravnikar
Journal:  Am J Obstet Gynecol       Date:  1987-05       Impact factor: 8.661

View more
  1 in total

1.  Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?

Authors:  S Hathirat; M F Evans
Journal:  Can Fam Physician       Date:  2001-10       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.